TVTX Operating Cash Flow (Statement)
Travere Therapeutics Inc · Operating Cash Flow (Statement)
TVTX Operating Cash Flow (Statement)
Latest reported$58.07Mperiod ending
TVTX Quarterly Cash from Operations (-$3.38K → $58.07M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
TVTX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 58,071,000 | |
| -40,366,000 | |
| 60,678,000 | |
| 14,317,000 | |
| 4,983,000 | |
| -42,194,000 | |
| -35,720,000 | |
| -42,507,000 | |
| -40,243,000 | |
| -119,005,000 | |
| -70,473,000 | |
| -59,134,000 | |
| -69,297,000 | |
| -81,117,000 | |
| -54,640,000 | |
| -39,525,000 | |
| -36,806,000 | |
| -55,320,000 | |
| -26,877,000 | |
| 32,063,000 | |
| 6,496,000 | |
| -26,474,000 | |
| -13,870,000 | |
| 6,735,000 | |
| -6,453,000 | |
| -29,155,000 | |
| -4,492,000 | |
| -14,121,000 | |
| -19,109,000 | |
| -20,492,000 | |
| -3,565,000 | |
| -3,899,000 | |
| -2,760,000 | |
| -14,734,000 | |
| -854,000 | |
| 5,639,000 | |
| 5,394,000 | |
| -2,776,000 | |
| -6,763,000 | |
| 4,744,000 | |
| 3,990,000 | |
| -3,567,000 | |
| -2,549,000 | |
| 1,429,000 | |
| 7,899,433 | |
| -7,333,433 | |
| -9,094,447 | |
| -15,499,915 | |
| -11,449,715 | |
| -9,805,673 | |
| -8,146,726 | |
| -2,655,460 | |
| -2,208,398 | |
| -4,578,584 | |
| -2,736,738,991 | |
| -471,256 | |
| -9 | |
| 18 | |
| -18 | |
| -25 | |
| -24 | |
| -580 | |
| -91 | |
| -3,126 | |
| -18 | |
| 7,895 | |
| -4,519 | |
| -3,376 |